...
首页> 外文期刊>Journal of Medical Microbiology: An Official Journal of the Pathological Society of Great Britain and Ireland >Purified galactooligosaccharide, derived from a mixture produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonellaenterica serovar Typhimurium adhesion and invasion in vitro and in vivo
【24h】

Purified galactooligosaccharide, derived from a mixture produced by the enzymic activity of Bifidobacterium bifidum, reduces Salmonellaenterica serovar Typhimurium adhesion and invasion in vitro and in vivo

机译:从双歧双歧杆菌的酶活性产生的混合物中纯化的低聚半乳糖降低了沙门氏菌血清型鼠伤寒沙门氏菌的粘附和在体内外的侵袭

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The prebiotic Bimuno? is a mixture containing galactooligosaccharides (GOSs), produced by the galactosyltransferase activity of Bifidobacterium bifidum NCIMB 41171 using lactose as the substrate. Previous in vivo and in vitro studies demonstrating the efficacy of Bimuno? in reducing Salmonella enterica serovar Typhimurium (S. Typhimurium) colonization did not ascertain whether or not the protective effects could be attributed to the prebiotic component GOS. Here we wished to test the hypothesis that GOS, derived from Bimuno?, may confer the direct anti-invasive and protective effects of Bimuno?. In this study the efficacy of Bimuno?, a basal solution of Bimuno? without GOS [which contained glucose, galactose, lactose, maltodextrin and gum arabic in the same relative proportions (w/w) as they are found in Bimuno?] and purified GOS to reduce S. Typhimurium adhesion and invasion was assessed using a series of in vitro and in vivo models. The novel use of three dimensionally cultured HT-29-16E cells to study prebiotics in vitro demonstrated that the presence of ~5 mg Bimuno? ml?1 or ~2.5 mg GOS ml?1 significantly reduced the invasion of S. Typhimurium (SL1344nalr) (P&0.0001). Furthermore, ~2.5 mg GOS ml?1 significantly reduced the adherence of S. Typhimurium (SL1344nalr) (P&0.0001). It was demonstrated that cells produced using this system formed multi-layered aggregates of cells that displayed excellent formation of brush borders and tight junctions. In the murine ligated ileal gut loops, the presence of Bimuno? or GOS prevented the adherence or invasion of S. Typhimurium to enterocytes, and thus reduced its associated pathology. This protection appeared to correlate with significant reductions in the neutral and acidic mucins detected in goblet cells, possibly as a consequence of stimulating the cells to secrete the mucin into the lumen. In all assays, Bimuno? without GOS conferred no such protection, indicating that the basal solution confers no protective effects against S. Typhimurium. Collectively, the studies presented here clearly indicate that the protective effects conferred by Bimuno? can be attributed to GOS.
机译:益生元Bimuno?是双歧双歧杆菌NCIMB 41171的半乳糖基转移酶活性产生的低聚半乳糖(GOS)混合物,使用乳糖作为底物。先前的体内和体外研究证明Bimuno?在减少肠炎沙门氏菌血清型鼠伤寒沙门氏菌(S. Typhimurium)的定殖过程中,并不确定保护作用是否可归因于益生元组分GOS。在这里,我们希望检验以下假设:源自Bimuno?的GOS可能赋予Bimuno?直接的抗侵袭和保护作用。在这项研究中,Bimuno?的基本溶液Bimuno?的功效。不含GOS(其葡萄糖,半乳糖,乳糖,麦芽糖糊精和阿拉伯树胶的相对比例(w / w)与Bimuno?中的含量相同)和纯化的GOS可以减少鼠伤寒沙门氏菌。体外和体内模型。三维培养的HT-29-16E细胞在体外研究益生元的新颖用途证明了〜5 mg Bimuno?的存在。 ml?1或〜2.5 mg GOS ml?1显着减少了鼠伤寒沙门氏菌(SL1344nalr)的侵袭(P <0.0001)。此外,〜2.5mg GOS ml-1显着降低了鼠伤寒沙门氏菌(SL1344nalr)的粘附(P <0.0001)。证明了使用该系统产生的细胞形成了多层的细胞聚集体,表现出极好的刷状边界和紧密连接。在小鼠结扎的回肠肠环中,是否存在Bimuno? GOS或GOS阻止了鼠伤寒沙门氏菌粘附或侵入肠细胞,从而减少了其相关的病理。这种保护作用似乎与杯状细胞中检测到的中性和酸性粘蛋白的显着减少有关,这可能是刺激细胞将粘蛋白分泌到管腔中的结果。在所有检测中,Bimuno吗?没有GOS的话就没有这种保护作用,表明该基础溶液对鼠伤寒沙门氏菌没有任何保护作用。总的来说,这里提出的研究清楚地表明Bimuno?可以归因于GOS。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号